Correction to: Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

DOI: https://doi.org/10.1093/ofid/ofae546

2024-09-30

Abstract:[This corrects the article DOI: 10.1093/ofid/ofae344.].

What problem does this paper attempt to address?

Erratum to “The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China”

Jie Lu,Huimin Li,Fang Dong,Jin Shi,Hui Yang,Shujing Han,Ping Chu,Yanlin Zhao,Wenqi Song,Yongli Guo,Shunying Zhao

DOI: https://doi.org/10.1155/2018/4360219

2018-09-06

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2017/5857369.].

biotechnology & applied microbiology,medicine, research & experimental
Erratum: Detection of two alphaviruses: Middelburg virus and Sindbis virus from enzootic amplification cycles in southwestern Uganda

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2024.1469636

2024-08-20

Abstract:[This corrects the article DOI: 10.3389/fmicb.2024.1394661.].
Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

DOI: https://doi.org/10.1093/cid/ciae257

IF: 20.999

2024-06-07

Clinical Infectious Diseases

Abstract:An error appeared in the corrected proof publication of this article (Siedner and Sax. "Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019." Clin Infect Dis ; https://doi.org/10.1093/cid/ciae154). An incorrect citation was used for a study discussed in the manuscript, and the manuscript did not include recent information regarding validity concerns about that trial. In the final paragraph, the sentence "Furthermore, another randomized, placebo-controlled trial of metformin, albeit with a different dosing strategy, showed no benefit [12]" should be updated to:

immunology,infectious diseases,microbiology
Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

DOI: https://doi.org/10.1177/24755303231195885

Abstract:[This corrects the article DOI: 10.1177/2475530320954279.].
Correction to: The Burden and Impact of Early Post-transplant Multidrug-Resistant Organism Detection Among Renal Transplant Recipients, 2005-2021

DOI: https://doi.org/10.1093/ofid/ofae541

2024-09-20

Abstract:[This corrects the article DOI: 10.1093/ofid/ofae060.].
Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Yoshie Hosaka,Yan Yan,Toshio Naito,Rieko Oyama,Koji Tsuchiya,Norio Yamamoto,Shuko Nojiri,Satoshi Hori,Kazuhisa Takahashi,Yoko Tabe

DOI: https://doi.org/10.3389/fmicb.2024.1478638

2024-08-23

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.944369.].
Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [ Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S339]

Muzamil Hassan,Raquel Duarte,Victor Mabayoje,Therese Dix-Peek,Caroline Dickens,Akeem Lasisi,Saraladevi Naicker

DOI: https://doi.org/10.1016/j.ekir.2024.05.018

2024-05-17

Abstract:[This corrects the article DOI: 10.1016/j.ekir.2024.02.699.].
Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"

Abdul-Rahman Azizogli,Varun Pai,Francesco Coppola,Roya Jafari,Joseph B Dodd-O,Rohan Harish,Bhavani Balasubramanian,Jatin Kashyap,Amanda M Acevedo-Jake,Petr Kral,Vivek A Kumar

DOI: https://doi.org/10.1021/acsomega.4c06853

IF: 4.1

2024-08-16

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.2c06384.].
Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078

Ma. Sheila M. de Jesus,Allan Patrick G. Macabeo,John Donnie A. Ramos,Von Novi O. de Leon,Kaori Asamitsu,Takashi Okamoto

DOI: https://doi.org/10.3390/molecules29030626

IF: 4.6

2024-01-29

Molecules

Abstract:Molecules, Vol. 29, Pages 626: Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078 Molecules doi: 10.3390/molecules29030626 Authors: Ma. Sheila M. de Jesus Allan Patrick G. Macabeo John Donnie A. Ramos Von Novi O. de Leon Kaori Asamitsu Takashi Okamoto There was an error in the original publication [...]

chemistry, multidisciplinary,biochemistry & molecular biology
Corrigendum to Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study

DOI: https://doi.org/10.1177/20499361241263641

2024-06-20

Abstract:[This corrects the article DOI: 10.1177/20499361241256290.].
Corrigendum to "Unravelling the diversity of Anaplasma species circulating in selected African wildlife hosts by targeted 16S microbiome analysis" [Current Research in Microbial Sciences Volume 5 (2023) 100198]

S Marcus Makgabo,Kelly A Brayton,Marinda C Oosthuizen,Nicola E Collins

DOI: https://doi.org/10.1016/j.crmicr.2024.100279

2024-10-05

Abstract:[This corrects the article DOI: 10.1016/j.crmicr.2023.100198.].
Corrigendum: Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China.

Wentao Zhu,Xiaoxia Wang,Yujin Lin,Lvfen He,Rui Zhang,Chuan Wang,Xiong Zhu,Tian Tang,Li Gu

DOI: https://doi.org/10.3389/fpubh.2024.1397325

IF: 5.2

2024-01-01

Frontiers in Public Health

Abstract:[This corrects the article DOI: 10.3389/fpubh.2023.1273745.].
Erratum: Glycemic control among patients with type 2 diabetes in a low resource setting in Rwanda: a prospective cohort study. The Pan African Medical Journal. 2022;43:74

PanAfrican Medical Journal

DOI: https://doi.org/10.11604/pamj.2023.44.123.39538

2023-01-01

Pan African Medical Journal

Abstract:[This corrects the article DOI: 10.11604/pamj.2022.43.74.35639.].
Corrigendum to "trend of HIV-1 Drug Resistance in China: A Systematic Review and Meta-Analysis of Data Accumulated over 17 Years (2001-2017)" [eclinicalmedicine 18 (2020) 100238].

Lulu Zuo,Kai Liu,Honglian Liu,Yihong Hu,Zhijie Zhang,Jianru Qin,Qinggang Xu,Ke Peng,Xia Jin,Jian-Hua Wang,Chiyu Zhang

DOI: https://doi.org/10.1016/j.eclinm.2020.100696

IF: 15.1

2021-01-01

EClinicalMedicine

Abstract:[This corrects the article DOI: 10.1016/j.eclinm.2019.100238.].
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

Wonderful T Choga,Ontlametse T Bareng,Natasha O Moraka,Dorcas Maruapula,Irene Gobe,Nokuthula S Ndlovu,Boitumelo J L Zuze,Patience C Motshosi,Kedumetse B Seru,Teko Matsuru,Matshwenyego Boitswarelo,Mogomotsi Matshaba,Tendani Gaolathe,Mosepele Mosepele,Joseph Makhema,Trevor J M Tamura,Jonathan Z Li,Roger Shapiro,Shahin Lockman,Simani Gaseitsiwe,Sikhulile Moyo

DOI: https://doi.org/10.1093/ofid/ofae344

2024-06-28

Open Forum Infectious Diseases

Abstract:Abstract Background We evaluated naturally occurring nirmatrelvir-ritonavir (NTV/r) resistance-associated mutations (RAMs) among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains from Botswana, a country with no NTV/r use to date, in order to recommend the usage of the agent for high-risk patients with coronavirus disease 2019 (COVID-19). Methods We conducted a retrospective analysis using 5254 complete SARS-CoV-2 sequences from Botswana (September 2020–September 2023). We evaluated the mutational landscape of SARS-CoV-2 3-Chymotrypsin-like protease (3CLpro) relative to the highlighted list of RAMs granted Food and Drug Administration Emergency Use Authorization in 2023. Results The sequenced 5254 samples included Beta variants of concerns (VOCs; n = 323), Delta VOCs (n = 1314), and Omicron VOCs (n = 3354). Overall, 77.8% of the sequences exhibited at least 1 polymorphism within 76/306 amino acid positions in the nsp5 gene. NTV/rRAMs were identified in 34/5254 (0.65%; 95% CI, 0.43%–0.87%) and occurred at 5 distinct positions. Among the NTV/r RAMS detected, A191V was the most prevalent (24/34; 70.6%). Notably, T21I mutation had a prevalence of 20.6% (7/34) and coexisted with either K90R (n = 3) polymorphism in Beta sequences with RAMs or P132H (n = 3) polymorphism for Omicron sequences with RAMs. Other NTV/r RAMs detected included P108S, with a prevalence of 5.88% (2/34), and L50F, with a prevalence of 2.94% (1/34). NTV/r RAMs were significantly higher (P < .001) in Delta (24/35) compared with Beta (4/34) and Omicron (6/34) sequences. Conclusions The frequency of NTV/r RAMs in Botswana was low. Higher rates were observed in Delta VOCs compared to Omicron and Beta VOCs. As NTV/r use expands globally, continuous surveillance for drug-resistant variants is essential, given the RAMs identified in our study.

immunology,infectious diseases,microbiology
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [ Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]

Maxime Teisseyre,Sonia Boyer-Suavet,Marion Crémoni,Vesna Brglez,Vincent Esnault,Barbara Seitz-Polski

DOI: https://doi.org/10.1016/j.ekir.2024.05.020

2024-05-23

Abstract:[This corrects the article DOI: 10.1016/j.ekir.2021.01.022.].
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Rui Xiong,Leike Zhang,Shiliang Li,Yuan Sun,Minyi Ding,Yong Wang,Yongliang Zhao,Yan Wu,Weijuan Shang,Xiaming Jiang,Jiwei Shan,Zihao Shen,Yi Tong,Liuxin Xu,Yu Chen,Yingle Liu,Gang Zou,Dimitri Lavillette,Zhenjiang Zhao,Rui Wang,Lili Zhu,Gengfu Xiao,Ke Lan,Honglin Li,Ke Xu

DOI: https://doi.org/10.1007/S13238-020-00801-Y

2020-01-01

Protein & Cell

Abstract:In the original publication the author’s name ‘Dimitri Lavillete’ is published incorrectly. The correct author name should be spelt as ‘Dimitri Lavillette’ is provided in this correction.
Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1249100

IF: 7.3

2023-07-12

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.964525.].

immunology
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

Richard T. Eastman,Jacob S. Roth,Kyle R. Brimacombe,Anton Simeonov,Min Shen,Samarjit Patnaik,Matthew D. Hall

DOI: https://doi.org/10.1021/acscentsci.0c00747

IF: 18.2

2020-06-16

ACS Central Science

Abstract:[This corrects the article DOI: 10.1021/acscentsci.0c00489.].

chemistry, multidisciplinary
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]

David Hodgson,Neil Wilkins,Edwin van Leeuwen,Conall H Watson,Jonathan Crofts,Stefan Flasche,Mark Jit,Katherine E Atkins

DOI: https://doi.org/10.1016/j.lanepe.2024.101073

2024-09-11

Abstract:[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.].

Correction to: Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

Erratum to “The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China”

Erratum: Detection of two alphaviruses: Middelburg virus and Sindbis virus from enzootic amplification cycles in southwestern Uganda

Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

Correction to: The Burden and Impact of Early Post-transplant Multidrug-Resistant Organism Detection Among Renal Transplant Recipients, 2005-2021

Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Corrigendum to "WCN24-1105 PHARMACOGENETIC RISK FACTORS FOR TENOFOVIR-INDUCED KIDNEY TUBULAR DYSFUNCTION AMONG HIV-POSITIVE ADULT NIGERIANS" [ Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S339]

Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"

Correction: de Jesus et al. Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-κB Cascade: In Vitro and In Silico Investigations. Molecules 2022, 27, 1078

Corrigendum to Prevalence of syphilis among people living with HIV who attend a large urban antiretroviral therapy clinic in Panama: a cross-sectional epidemiological study

Corrigendum to "Unravelling the diversity of Anaplasma species circulating in selected African wildlife hosts by targeted 16S microbiome analysis" [Current Research in Microbial Sciences Volume 5 (2023) 100198]

Corrigendum: Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China.

Erratum: Glycemic control among patients with type 2 diabetes in a low resource setting in Rwanda: a prospective cohort study. The Pan African Medical Journal. 2022;43:74

Corrigendum to "trend of HIV-1 Drug Resistance in China: A Systematic Review and Meta-Analysis of Data Accumulated over 17 Years (2001-2017)" [eclinicalmedicine 18 (2020) 100238].

Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [ Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity

Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]